Submitted by Anonymous (not verified) on 19 September 2024 - 13:17
Opinion/decision on a Paediatric investigation plan (PIP): Otezla, apremilast, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0469/2020
Source: